NEW YORK, Jan. 6, 2020 /PRNewswire/ --
Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029
Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN
Key Questions Answered in this Report: What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications? What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope? What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market? What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies? What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products? What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029? What are the different recombinant supplement products involved in cell culture? Which product type dominate the market in 2018 and why? Which product type are expected to witness highest growth rate and to dominate in market in 2029? What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029? What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market? Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market? What are the key players of the global recombinant cell culture supplements market and what is their role in the market?
Global Recombinant Cell Culture Supplements Market Forecast, 2019-2029 The recombinant cell culture supplements market analysis projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million revenue in 2018, in terms of value. The recombinant cell culture supplements market growth has been primarily attributed to the major drivers in this market such as advantages offered by recombinant cell culture supplements and the promising impact displayed by them in culturing cells act as drivers for the growth of the market.Moreover, an increase in funding and investment supporting the advancement of life-science research with an ever-increasing demand for advanced cell culture systems have boosted the adoption rate of recombinant cell-culture supplements products. However, there are significant challenges which are restraining the market growth.These challenges include the shortage of skilled professionals and lack of proper laboratory infrastructure. Further, high cost of the cell culturing process and complications involved in it are also acting as challenge for the market. Expert Quote "The most important advantage of utilizing these recombinant proteins is that they facilitate large batch biomanufacturing with minimal risk of contamination and improved adhesion. Another advantage is that it involves animal-free manufacturing which in turn simplifies regulatory issues and export-import issues." Scope of the Market Intelligence on Recombinant Cell Culture Supplements Market The recombinant cell culture supplements market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements. The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market. Market Segmentation The recombinant cell culture supplements market segmentation (on the basis of product) is further segmented into recombinant insulin, transferrin, albumin, among others. The recombinant cell culture supplements market segmentation (on the basis of application) is segmented into stem cell and regenerative medicine, bio-production, and academic and research. The recombinant cell culture supplements market segmentation (on the basis of region) is segmented into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World. Key Companies in the Recombinant Cell Culture Supplements Market The key manufacturers who have been contributing significantly to the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others. Countries Covered North America U.S. Canada Europe Germany France U.K. Italy Spain The Netherlands Rest-of-Europe Asia-Pacific China Japan South Korea India Australia Rest-of-Asia-Pacific Latin America Brazil Mexico Rest-of-Latin America Rest-of-the-World Russia Israel Kingdom of Saudi Arabia (K.S.A.)
Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
SOURCE Reportlinker
Read more:
- Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 - The Medicine Maker - January 7th, 2025
- Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. - openPR - January 7th, 2025
- Stem-cell therapies that work: 10 Breakthrough Technologies 2025 - MIT Technology Review - January 5th, 2025
- 1st stem cell therapy, new HIV drug approved - ecns - January 5th, 2025
- Science fiction turned reality? Stem cell therapy set to repair child's heart - Ynetnews - January 3rd, 2025
- Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology - The Manila Times - January 1st, 2025
- Allogeneic Stem Cell Transplantation Market Size to Expand Lucratively by 2031 - openPR - January 1st, 2025
- Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells - Nature.com - December 30th, 2024
- Why Medical Tourists are Choosing Mexico: The Affordable Alternative for Advanced Stem Cell Treatments - openPR - December 30th, 2024
- Induced Pluripotent Stem Cells (iPSC) Production Market: Trends, Growth, and the Role of AI - openPR - December 30th, 2024
- Stem cells 'instructed' to form specific tissues and organs - New Atlas - December 28th, 2024
- Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia - Medpage Today - December 28th, 2024
- Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine - Galveston County Daily News - December 28th, 2024
- Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine - Voice Of Alexandria - December 28th, 2024
- U.S. Stem Cell Therapy Market Revenue to Attain USD 17.70 Bn by 2033 - Precedence Research - December 27th, 2024
- Here are some biggest medical breakthroughs of 2024 - Medical Buyer - December 27th, 2024
- Researchers from Korea University explore how ascorbic acid and FGF4 revolutionize regenerative medicine - EurekAlert - December 27th, 2024
- Regenerative Medicine Market to Skyrocket to USD 73,084.2 Million by 2033 at a 18.5% of CAGR - openPR - December 27th, 2024
- Stem cell therapy to correct heart failure in children could 'transform lives' - Fox News - December 25th, 2024
- Advancing type 1 diabetes therapy: autologous islet transplant breakthrough - Nature.com - December 25th, 2024
- Stem Cell Therapy Market to Triple in Value, Reaching USD 52.1 Billion by 2034 at a 12.1% of CAGR - openPR - December 25th, 2024
- Stem-cell therapies: A breakthrough in treating parkinson's, cancer, diabetes, and more - The Business Standard - December 25th, 2024
- Replay 2024 : 6 Biggest Medical Breakthroughs Of 2024 - NewsX - December 25th, 2024
- Tumbling stem cells? Watch how movement plays a part in their fate - Scope - December 20th, 2024
- SCD patients free of VOEs after treatment with gene-editing therapy - Sickle Cell Disease News - December 20th, 2024
- Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture - BSA bureau - December 20th, 2024
- Brain cells remain healthy after a month on the International Space Station, but mature faster than brain cells on Earth - EurekAlert - December 19th, 2024
- Reindeers Pave the Way for Regenerative Medicine - The Scientist - December 19th, 2024
- Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA (ibrutinib) in adult... - December 19th, 2024
- What Role Does Regenerative Medicine Play In The Management Of Type 1 And Type 2 Diabetes? - TheHealthSite - December 19th, 2024
- World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets - PR Newswire - December 17th, 2024
- Accelerated Biosciences and Stemmatters Collaborate to Offer iPSC Derived from Human Trophoblast Stem Cells - Business Wire - December 17th, 2024
- Stem Cells: Hope on the Horizon for Preterm Babies - Monash University - December 17th, 2024
- Stem Cell Transplant Offers No Difference in OS or PFS in Mantle Cell Lymphoma Compared with Maintenance Therapy Alone - OncoZine - December 17th, 2024
- Inside One Mans Journey with Multiple Myeloma - Men's Health - December 15th, 2024
- Stem Cells Market Size to Reach USD 48.83 Billion By 2034 - Exclusive Report by Precedence Research - BioSpace - December 13th, 2024
- Treating Heart Defects with Tissue-engineered Vascular Conduits - Yale School of Medicine - December 13th, 2024
- Tom Curry: England flanker has stem-cell therapy in bid to make 2027 World Cup - BBC.com - December 13th, 2024
- Stem Cell Manufacturing Market Dynamics Key Drivers Challenges and Technological Innovations - Set to reach USD 26.6 billion by 2033 - PharmiWeb.com - December 13th, 2024
- Stem Cell Therapy Market Is Expected To Reach Revenue Of USD 54.7 Bn By 2033, At 12.6% CAGR: Dimension Market Research - The Manila Times - December 13th, 2024
- Stem cell transplantation could save the coral reefs - Ynetnews - December 13th, 2024
- Vitrification Market | Driving Innovations in Cryopreservation for Fertility Treatments and Regenerative - EIN News - December 13th, 2024
- Workshop on Regenerative Medicine concludes at SKUAST-K - Greater Kashmir - December 13th, 2024
- High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphoma - News-Medical.Net - December 11th, 2024
- Stem Cell Therapy Market Is Expected To Reach Revenue Of - GlobeNewswire - December 11th, 2024
- Stem Cell Therapy Market to Worth Over US$ 2,612.92 Million By 2033 | Astute Analytica - GlobeNewswire - December 11th, 2024
- Changes in Blood Cell Production Over the Lifetime | Newswise - Newswise - December 7th, 2024
- Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer - Medical Xpress - December 5th, 2024
- Stem cell therapy TED-A9 showing safety and early efficacy in trial - Parkinson's News Today - December 5th, 2024
- BMP-2 loaded scaffold for stem and immune cell recruitment in therapeutic applications - News-Medical.Net - December 5th, 2024
- Stem Cell Treatment May Help To Cure Vision Loss - Anti Aging News - December 5th, 2024
- BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024... - December 3rd, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 3rd, 2024
- Enhancing the efficacy of cell transplantation therapy for stroke or traumatic brain injury - Medical Xpress - December 1st, 2024
- Apheresis in Cellular Therapies: Unlocking Quality for CAR T and Stem Cell Treatments, Upcoming Webinar Hosted by Xtalks - PR Web - November 29th, 2024
- Stem Cell Therapy Market is expected to Double Its Size by Upcoming Decade - openPR - November 29th, 2024
- AmeraCell Revolutionizes Regenerative Medicine with Accessible and Affordable Stem Cell Clinics - openPR - November 29th, 2024
- Making fat cells skinny: Findings could lead to new, more effective therapies for managing diabetes - Medical Xpress - November 25th, 2024
- Designer Cells Could Be the Key to Autoimmune Disease Treatment - VICE - November 25th, 2024
- Why do athletes store their body cells? - The Times of India - November 22nd, 2024
- What Stem Cell Treatments Canand CantDo - Men's Health - November 22nd, 2024
- Can Regenerative Medicine Speed Up Sports Injury Recovery? Expert Weighs In - Onlymyhealth - November 22nd, 2024
- How Stem Cell Therapy Works for Knee Osteoarthritis: A Cutting-Edge Treatment Explained - Salon Priv Magazine - November 22nd, 2024
- Genting breaks ground on stem cell facility in Bali, Indonesia - theSun - November 22nd, 2024
- A New Stem Cell Therapy for Parkinson's Disease Has Been Confirmed Safe and Effective for the First Time - AccessWire - November 20th, 2024
- More stem cells for sickle cell gene therapy readied with motixafortide - Sickle Cell Disease News - November 20th, 2024
- Isolation and identification of patient-derived liver cancer stem cells and development of personalized treatment strategies - Journal of... - November 20th, 2024
- Stem Cell Therapy Market Expected To Reach 31.33 Billion, - GlobeNewswire - November 18th, 2024
- A look at the broad range of therapies offered sponsored by NeoGenix Stem Cell and Regenerative Therapies - WCNC.com - November 18th, 2024
- Worlds first stem-cell treatment restores vision for patients with severe corneal damage - The Times of India - November 18th, 2024
- MEDEZE Group Wins Industry Champions of the Year at ACES Award, Leads Stem Cell Innovation - Bangkok Post - November 18th, 2024
- Human vision restored by stem cell replacement in regenerative medicine breakthrough - Medical Xpress - November 12th, 2024
- Stem cells grown in space show super powers but theres a catch - Study Finds - November 12th, 2024
- Developing the Cell-Based Therapies of the Future - University of Miami - November 12th, 2024
- Japan performs world's first stem cell-treatment to restore vision - DrugsControl.org - November 12th, 2024
- HRT, Stem Cells, & Nitric Oxide: What This Longevity Expert Wants You To Know - mindbodygreen - November 10th, 2024
- Stem Cell Market Potential: Revolutionizing Regenerative Medicine and Therapeutics - openPR - November 10th, 2024
- Whats coming up at Cell & Gene Therapy International Europe 2024? - RegMedNet - November 10th, 2024
- The Team Stem Cell Medicine Ltd. - November 8th, 2024
- Stem Cell Medicine (SCM) Receives Israeli Government Funding for Gene ... - November 8th, 2024
Recent Comments